Claudia M. Nicolae

Claudia M. Nicolae

Auto-generated profile, based on publicly available information

Claudia M. Nicolae

Department of Molecular and Precision Medicine, The Pennsylvania State University College of Medicine , Hershey, PA 17033

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2005 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
TBTherese Bengtsson
Therese Bengtsson
AAAttila Aszodi
Attila Aszodi
CNClaudia Nicolae
Claudia Nicolae
EHErnst B. Hunziker
Ernst B. Hunziker
ELEvy Lundgren-ÅkErlund
Evy Lundgren-ÅkErlund
RFReinhard FäsSler
Reinhard FäsSler
Integrin α10β1 is a collagen-binding integrin expressed on chondrocytes. In order to unravel the role of the α10 integrin during development, we generated mice carrying a constitutive deletion of the α10 integrin gene. The mutant mice had a normal lifespan and were fertile but developed a growth retardation of the long bones. Analysis of the skeleton revealed defects in the growth plate after birth characterized by a disturbed columnar arrangement of chondrocytes, abnormal chondrocyte shape and reduced chondrocyte proliferation. Electron microscopy of growth plates from newborn mice revealed an increased number of apoptotic chondrocytes and reduced density of the collagen fibrillar network compared to these structures in control mice. These results demonstrate that integrin α10β1 plays a specific role in growth plate morphogenesis and function.

1 May 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CNClaudia M. Nicolae
Claudia M. Nicolae
EAErin R. Aho
Erin R. Aho
AVAlexander H. S. Vlahos
Alexander H. S. Vlahos
KCKatherine N. Choe
Katherine N. Choe
SDSubhajyoti De
Subhajyoti De
GMGeorge-Lucian Moldovan
George-Lucian Moldovan
All cells rely on genomic stability mechanisms to protect against DNA alterations. PCNA is a master regulator of DNA replication and S-phase-coupled repair. PCNA post-translational modifications by ubiquitination and SUMOylation dictate how cells stabilize and re-start replication forks stalled at sites of damaged DNA. PCNA mono-ubiquitination recruits low fidelity DNA polymerases to promote error-prone replication across DNA lesions. Here, we identify the mono-ADP-ribosyltransferase PARP10/ARTD10 as a novel PCNA binding partner. PARP10 knockdown results in genomic instability and DNA damage hypersensitivity. Importantly, we show that PARP10 binding to PCNA is required for translesion DNA synthesis. Our work identifies a novel PCNA-linked mechanism for genome protection, centered on post-translational modification by mono-ADP-ribosylation.

1 June 2015 in Development
Verified
Journal Article
Open access
PDF file
XDXuchen Duan
Xuchen Duan
YMYurie Murata
Yurie Murata
YLYanqiu Liu
Yanqiu Liu
CNClaudia Nicolae
Claudia Nicolae
BOBjorn R. Olsen
Bjorn R. Olsen
ABAgnes D. Berendsen
Agnes D. Berendsen
Vascular endothelial growth factor A (Vegfa) has important roles in endochondral bone formation. Osteoblast precursors, endothelial cells and osteoclasts migrate from perichondrium into primary ossification centers of cartilage templates of future bones in response to Vegfa secreted by (pre)hypertrophic chondrocytes. Perichondrial osteolineage cells also produce Vegfa, but its function is not well understood. By deleting Vegfa in osteolineage cells in vivo, we demonstrate that progenitor-derived Vegfa is required for blood vessel recruitment in perichondrium and the differentiation of osteoblast precursors in mice. Conditional deletion of Vegfa receptors indicates that Vegfa-dependent effects on osteoblast differentiation are mediated by Vegf receptor 2 (Vegfr2). In addition, Vegfa/Vegfr2 signaling stimulates the expression and activity of Indian hedgehog, increases the expression of β-catenin and inhibits Notch2. Our findings identify Vegfa as a regulator of perichondrial vascularity and osteoblast differentiation at early stages of bone development.

1 May 2012 in Developmental Cell
Verified
Journal Article
Closed access
AIAndreia Ionescu
Andreia Ionescu
EKElena Kozhemyakina
Elena Kozhemyakina
CNClaudia Nicolae
Claudia Nicolae
KKKlaus H. Kaestner
Klaus H. Kaestner
BOBjorn R. Olsen
Bjorn R. Olsen
ALAndrew B. Lassar
Andrew B. Lassar

4 May 2016 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
KCKatherine N Choe
Katherine N Choe
CNClaudia M Nicolae
Claudia M Nicolae
DCDaniel Constantin
Daniel Constantin
YKYuka Imamura Kawasawa
Yuka Imamura Kawasawa
MDMaria Rocio Delgado‐Diaz
Maria Rocio Delgado‐Diaz
GMGeorge-Lucian Moldovan
George-Lucian Moldovan

19 July 2018 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ESEmily M Schleicher
Emily M Schleicher
AGAdri M Galvan
Adri M Galvan
YIYuka Imamura-Kawasawa
Yuka Imamura-Kawasawa
GMGeorge-Lucian Moldovan
George-Lucian Moldovan
CNClaudia M Nicolae
Claudia M Nicolae
During carcinogenesis, cells are exposed to increased replication stress due to replication fork arrest at sites of DNA lesions and difficult to replicate genomic regions. Efficient fork restart and DNA repair are important for cancer cell proliferation. We previously showed that the ADP-ribosyltransferase PARP10 interacts with the replication protein proliferating cell nuclear antigen and promotes lesion bypass by recruiting specialized, non-replicative DNA polymerases. Here, we show that PARP10 is overexpressed in a large proportion of human tumors. To understand the role of PARP10 in cellular transformation, we inactivated PARP10 in HeLa cancer cells by CRISPR/Cas9-mediated gene knockout, and overexpressed it in non-transformed RPE-1 cells. We found that PARP10 promotes cellular proliferation, and its overexpression alleviates cellular sensitivity to replication stress and fosters the restart of stalled replication forks. Importantly, mouse xenograft studies showed that loss of PARP10 reduces the tumorigenesis activity of HeLa cells, while its overexpression results in tumor formation by non-transformed RPE-1 cells. Our findings indicate that PARP10 promotes cellular transformation, potentially by alleviating replication stress and suggest that targeting PARP10 may represent a novel therapeutic approach.